Redwood Park Advisors’s AbbVie ABBV Stock Holding History

Redwood Park Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.9K	Buy	222 +1	+0.5%	+$215	0.04%	98
2026 Q1	$48K	Buy	221 +2	+0.9%	+$444	0.03%	104
2025 Q4	$50K	Buy	219 +1	+0.5%	+$228	0.03%	100
2025 Q3	$50.4K	Buy	218 +2	+0.9%	+$407	0.03%	96
2025 Q2	$40.1K	Sell	216 -9	-4%	-$1.67K	0.03%	113
2025 Q1	$47.1K	Hold	225	–	–	0.04%	97
2024 Q4	$40K	Buy	+225	New	+$41.4K	0.03%	114

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Redwood Park Advisors's ABBV Position: Q2 2026 in Review

Redwood Park Advisors increased its AbbVie (ABBV) stake by 0.45% in Q2 2026, buying an estimated $215 and bringing the position to 222 shares worth $55.9K. The position accounts for 0.04% of the portfolio, ranked #98.

Redwood Park Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Redwood Park Advisors held 222 shares of AbbVie worth $55.9K as of Q2 2026.
Redwood Park Advisors bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.04% of Redwood Park Advisors's portfolio in Q2 2026, its #98 holding.
Redwood Park Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.